Loading resource…

University of Zürich, Ludwig-Maximilians-Universität, University of Michigan, Mayo Clinic, University Hospital Würzburg, University of Texas Southwestern Medical Center, Leiden University Medical Center, University of Bergen, University of Birmingham
The document outlines the clinical guidelines established by the European Society of Endocrinology and the Endocrine Society for diagnosing and treating adrenal insufficiency caused by glucocorticoid therapy. It emphasizes the importance of careful monitoring and testing to assess the recovery of the hypothalamic-pituitary-adrenal (HPA) axis in affected patients. The guideline also discusses the implications of co-morbidities and medication interactions in the management of this condition.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology

Kiruddu DKA guidelines
Same clinical topic · Endocrinology

Pharmacotherapy for Obesity Management: 2025 Guidelines
Same clinical topic · Endocrinology

Management of DKA
Same clinical topic · Endocrinology

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY CONSENSUS STATEMENT ALGORITHM FOR MANAGEMENT OF ADULTS WITH TYPE 2 DIABETES — 2026 UPDATE
Same clinical topic · Endocrinology

GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CONGENITAL HYPOTHYROIDISM
Same clinical topic · Endocrinology

2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology

CANADIAN ADULT OBESITY CLINICAL PRACTICE GUIDELINE: PHARMACOTHERAPY FOR OBESITY MANAGEMENT IN ADULTS
Same clinical topic · Endocrinology

Nutritional Management of Diabetes SOP (2)
Same clinical topic · Endocrinology